Newer Oral Contraceptives and the Risk of Venous Thromboembolism

This publication has 38 references indexed in Scilit:

• Mortality from venous thromboembolism among young women in Europe: no evidence for any effect of third generation oral contraceptives.
  Journal of Epidemiology and Community Health, 1997
• End of the line for “third-generation-pill” controversy?
  The Lancet, 1997
• Oral contraceptives and venous thrombosis: different sensitivities to activated protein C in women using second‐ and third‐generation oral contraceptives
  British Journal of Haematology, 1997
• Oral contraceptives and mortality from venous thromboembolism
  The Lancet, 1996
• Mortality from venous thromboembolism and myocardial infarction in young adults in England and Wales
  The Lancet, 1996
• Mortality from venous thromboembolism and myocardial infarction in young women in the Netherlands
  The Lancet, 1996
• Recent oral contraceptive use patterns in four European countries: Evidence for selective prescribing of oral contraceptives containing third-generation progestogens
  The European Journal of Contraception & Reproductive Health Care, 1996
• Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease
  The Lancet, 1995
• Risk of idiopathic cardiovascular death and rionfatal venous thromboembolism in women using oral contraceptives with differing progestagen components
  The Lancet, 1995
• Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study
  The Lancet, 1995